Skip to content
DataLookout
Menu

INVITENCT07908407

Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

Percentage of patients who "agree" or "completely agree" in the Feasibility of Intervention Measure (Feasibility)
Timeframe: After pre-screening for clinical trials is complete (Up to 9 months)
Percentage of community providers who "agree" or "completely agree" in the Feasibility of Intervention Measure (Feasibility)
Timeframe: After enrollment is complete at the end of study period (Up to 24 months)
Percentage of patients who "agree" or "completely agree" in the Acceptability of Intervention Measure (Acceptability)
Timeframe: After pre-screening for clinical trials is complete (Up to 9 months)
Percentage of community providers who "agree" or "completely agree" in the Acceptability of Intervention Measure (Acceptability)
Timeframe: After enrollment is complete at the end of study period (Up to 24 months)
Percentage of patients who "agree" or "completely agree" in the Intervention Appropriateness Measure (Appropriateness)
Timeframe: After pre-screening for clinical trials is complete (Up to 9 months)
Percentage of community providers who "agree" or "completely agree" in the Intervention Appropriateness Measure (Appropriateness)
Timeframe: After enrollment is complete at the end of study period (Up to 24 months)
Percentage of remotely screened patients that are identified as eligible for a prostate or bladder cancer clinical trial at Fred Hutch (FH) and enroll in that clinical trial
Timeframe: Up to 9 months
Percentage of remotely screened patients that are identified as eligible or potentially eligible for a prostate or bladder cancer clinical trial at FH, and express interest in participating
Timeframe: Up to 9 months

Secondary (2)

Perceived barriers to participation in clinical trials
Distribution of participants by race and ethnicity among remotely pre-screened patients who enroll or indicate intent to enroll in a clinical trial

Arms and interventions

Group I (pre-screening)Experimental

Patients have their medical records reviewed by the research nursing team and are pre-screened for open clinical trials at Fred Hutch Cancer Center for 9 months. Patients NOT eligible for a clinical trial are notified and receive no further contact.

Group II (pre-screening, GU appointment)Experimental

Patients have their medical records reviewed by the research nursing team and are pre-screened for open clinical trials at Fred Hutch Cancer Center for 9 months. Patients who are immediately eligible for a clinical trial who are interested in learning more about the clinical trial(s) are contacted and scheduled for an appointment with a GU medical oncologist to discuss further. Patients who are immediately eligible for a clinical trial who are NOT interested receive no further contact. These patients may have the option for future pre-screening.

Group III (pre-screening, GU appointment, re-screening)Experimental

Patients have their medical records reviewed by the research nursing team and are pre-screened for open clinical trials at Fred Hutch Cancer Center for 9 months. Patients who are eligible for a clinical trial in the future upon disease progression or change in status who are interested in learning more about the clinical trial(s) are contacted and scheduled for an appointment with a GU medical oncologist to discuss further. Patients who are eligible for a clinical trial in the future upon disease progression or change in status who are interested in pursuing the clinical trial(s) upon eligibility, but do not wish to proceed to a GU appointment have the option to reach out at time of eligibility for re-screening and appointment. Patients who are eligible for a clinical trial in the future upon disease progression or change in status who are NOT interested in the clinical trial(s) they are eligible for and/or not interested in participation receive no further contact.

Other: Electronic Health Record Review, Prescreen, Rescreening, Survey Administration

Behavioral: Patient Navigation

Sites

1 site in 1 country

  • Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United States